This Week in Psychedelics - 10.30.20

ThisWeekinPsychedelics.png

Cannabis

  • New Zealand Marijuana Legalization Trails In Early Referendum Results, But More Votes To Be Counted (Marijuana Moment)

  • New Jersey Lawmakers Approve Bill Providing Medical Marijuana Patient Insurance Benefits (Marijuana Moment)

  • Study: Seniors Report Using Cannabis Products to Mitigate Symptoms Associated with Older Age (NORML)

  • Mississippi Supreme Court Won’t Consider Challenge To Medical Marijuana Measure Until After Election (Marijuana Moment)

  • South Dakota: Oglala Sioux Enacts Ordinance Legalizing Marijuana Use on Tribal Lands (NORML)

  • New Jersey Marijuana Sales Could Start Just Weeks After Election Day Under Key Senator’s Plan (Marijuana Moment)

  • Study suggests that cannabis can reduce OCD symptoms by half in short term (Hindustan Times)

  • Idaho Activists Submit 2022 Medical Marijuana Initiative Following 2020 Complications (Marijuana Moment)

  • Schools And NCAA Could Ban Marijuana Sponsorships Under Bill To Let Student Athletes Monetize Their Success (Marijuana Moment)

  • Virginia NORML Calls for Legalization to Protect Marijuana Consumers from Potentially Tainted Products (NORML)

  • South Dakota Voters Back Marijuana Legalization And Medical Cannabis Ballot Measures, Poll Finds (Marijuana Moment)

  • The Music Never Stops With Jerry Garcia’s Just-Launched Cannabis Collection (Forbes)

LSD

  • Killer High: Exploring the Phenomenon of LSD-Fuelled Murder (VICE)

  • The psychedelics revolution has arrived in New Zealand (The Spinoff)

Magic Mushrooms

  • Covid Can't Kill Mushrooms: The coronavirus has infected, but not killed, the movement to bring magic mushrooms to the masses (Rooster Magazine)

  • Expanding On Psilocybin Research, John Hopkins Hoping To Hear From More Users (CBS Baltimore)

MDMA

  • ‘Sorted’ for Es? Women and Ecstasy in 1990s Britain (Chacruna)

DMT

  • SLU professor is authority on drug that landed him in jail (WWNY-TV)

Ayahuasca

  • Ayahuasca Ceremonies and Tourism Return to Costa Rica (The Costa Rica Star)

  • Studies lift the veil on psychedelic brew ayahuasca, its mental health benefits and potential to treat depression and trauma (South China Morning Post)

  • Documentary looks at mystery medicine, Ayahuasca (The Leaf Online)

Mescaline

  • What Is Mescaline? A Guide to this Cactus-Derived Psychedelic (DoubleBlind)

Synthetic Cannabinoids

  • Synthetic cannabinoids linked to increased hospitalizations and deaths in older adults with COPD (Marijuana Business Daily)

  • Synthetic Cannabis Could Disrupt The Marijuana Industry In A Big Way (Green Entrepreneur)

Ketamine

  • Wearable Ketamine Delivery Device Developed As Alternative to Opioid-Based Pain Management (Lucid News)

  • Ketamine Helps People Dislike Themselves Less (Psychedelic Science Review)

  • Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain (Psilocybin Alpha)

  • Can Dissociative Side Effect of “Floating” Predict Response to Ketamine in MDD? (Psychiatry Advisor)

Miscellaneous

  • No Drugs Should Be Criminalized. It’s Time to Abolish the DEA. (Truthout)

  • ‘Drug Free USA Forever’ Stamps Launched By DEA, Postal Service And Miss America (Marijuana Moment)

  • Inside the ‘Psychedelic Exceptionalism’ Debate: Should All Drugs be Legal, or Just Pot and Psychedelics? (DoubleBlind)

  • Psilocybin Group Therapy Improves Demoralization for AIDS Survivors (Chacruna)

  • Children and Psychedelics: Re-examining Cultural Paradigms (Psychedelics Today)

  • International study finds 79% of individuals who microdose with psychedelics report improvements in their mental health (PsyPost)

  • Ketamine Meditation, Jungle Tripping and Modern-Day Shamans: Meet a ‘Psychedelic Concierge’ (VICE)

  • The Role of Psychedelic Plant Medicines in Addiction Treatment (The Fix)

  • A Collective Call for Accountability in Plant Medicine Experiences (Chacruna)

  • Who owns psychedelics: patents and state therapeutic access laws (New Amsterdam Psychedelic Law)

  • Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development (Psilocybin Alpha)

  • What do Santo Daime and Raves Have in, Common? The Answer Might Move You (Chacruna)

  • Journey Colab bags $3M from 'moonshot' fund to push new development model for psychedelic treatments (Fierce Biotech)

  • Where Witchcraft Meets Plant Medicine (DoubleBlind)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.